(Q67488169)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316069%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Pharmacokinetics of lomefloxacin in patients with cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316069%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

author name string

D. Lebrec

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316069

12 September 2022

C. Gaudin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316069

12 September 2022

J. P. Benhamou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316069

12 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1316069

12 September 2022

publication date

1 April 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316069%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

6 April 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1316069

full work available at URL

12 September 2022

https://api.elsevier.com/content/article/PII:000293439290307W?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90307-W

https://api.elsevier.com/content/article/PII:000293439290307W?httpAccept=text/plain

4 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90307-W

American Journal of Medicine

4 December 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316069%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316069%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

41S-44S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316069%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

4A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316069%20AND%20SRC:MED&resulttype=core&format=json

In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones

14 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90307-W

In vitro and in vivo activity of NY-198, a new difluorinated quinolone

4 December 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90307-W

In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents

4 December 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90307-W

Transection of the oesophagus for bleeding oesophageal varices

4 December 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90307-W

Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses

4 December 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90307-W

Pharmacokinetics and safety of single oral doses of lomefloxacin

4 December 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90307-W

4 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316069%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference